RET-IN-13
RET-IN-13 (compound 1), a quinoline compound, is a potent RET inhibitor with IC50s of 0.5 nM, 0.9 nM for RET (WT) and RET (V804M), respectively. RET-IN-13 has the potential for tumors or intestinal diseases related to abnormal activation of RET research[1].
Product Specifications
CAS Number
[2684258-54-4]
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-13.html
Solubility
10 mM in DMSO
Smiles
O=C(CC1=CC=C(C2=CN=C3C=C(C(OC)=CC3=C2)OC)N=C1)NC4=C(F)C=C(CN5CCN(CC5)CC)C(C(F)(F)F)=C4
Molecular Formula
C32H33F4N5O3
Molecular Weight
611.63
References & Citations
[1]Jiansong Wang, et al. Quinoline compounds. WO2021164742A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15374401 1 Vial
Lentiviral human ERI2 sgRNA gene knockout kit - Lentiviral human ERI2 sgRNA gene knockout kit (100)
Ask
View Details